TSRI Scientists Discover Possible New Target for Treating Brain Inflammation LA JOLLA, CA January 12, 2015 A team led by scientists at The Scripps Research Institute (TSRI) has identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited neurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that inhibit this enzyme.
This treatment approach may also turn out to be useful against more common conditions that involve brain inflammation a category that includes multiple sclerosis, Alzheimer's, Parkinson's, ALS and secondary damage after stroke and head injuries. Such inflammation often fails to respond to standard anti-inflammatory drugs.
This finding is a good example of what can be gained from studying enzymes linked to rare human genetic disorders, said Benjamin F. Cravatt, chair of TSRI's Department of Chemical Physiology and member of TSRI's Skaggs Institute for Chemical Biology.
Rare and Mysterious Disorder
The new study by Cravatt's team, which appears as a Nature Chemical Biology Advance Online Publication on January 12, stemmed from investigations of PHARC, a rare and mysterious inherited disorder that was first described by Norwegian researchers in 2009. Named for its unique set of typical symptoms (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa and cataract) PHARC usually manifests in early adolescence and progressively worsens with age.
In 2010, PHARC was linked to gene mutations that inactivate the enzyme ABHD12. The finding prompted Cravatt and his laboratory to develop a mouse model of the disease in which the ABHD12 gene is similarly inactivated. Studies of those PHARC mice revealed that the ABHD12 enzyme normally breaks down immune-signaling lipid molecules called lysophosphatidylserines (lyso-PSs) in the brain. ABHD12's absence in the PHARC mice leads to an abnormal buildup of lyso-PSs and subsequent neuroinflammation.
Having identified an enzyme that normally breaks down lyso-PS molecules, Cravatt and his laboratory set out, in the new study, to find an enzyme that makes lyso-PSs. In principle, such an enzyme could be targeted with compounds that inhibit its activity, to dial down lyso-PS levels in the nervous system and thus treat PHARC.
Sophisticated Test and a Weight-Loss Drug
To find a lyso-PS-making enzyme, Cravatt lab Research Associate Siddhesh S. Kamat led the effort to develop a sophisticated test for detecting the enzyme-mediated conversion of precursor phosphatidylserine (PS) molecules to lyso-PSs. Using this test we discovered a cryptic yet distinct lyso-PS-making enzyme activity in the mouse brain, said Kamat.
The tests revealed especially high levels of this activity in the cerebellum, a brain region strongly impacted in PHARC.
The team also found that this lyso-PS-making activity could be powerfully blocked in the lab dish by the weight-loss drug tetrahydrolipstatin (THL, also known as Orlistat and Xenical). THL is a known inhibitor of multiple enzymes, and the team was able to link the lyso-PS-making activity in mouse brain specifically to one of these enzymes: a previously uncharacterized enzyme called ABHD16A.
In further work, Cravatt's team began a collaboration with the laboratory of chemist Amy R. Howell at the University of Connecticut to find a more potent and selective inhibitor of ABHD16A, initially as a tool for studying the enzyme.
Dr. Howell very generously allowed us to screen her library of THL-related compounds for ABHD16A inhibitors, Cravatt said.
A Better Inhibitor
The team eventually isolated a small-molecule compound, KC01, that disrupts ABHD16A activity in mammalian cells more selectively than THL does. Using this inhibitor with advanced chemical proteomic and metabolomics techniques, we were able to confirm that ABHD16A is a major producer of lyso-PS molecules in several different mammalian cells, Kamat said.
The team found that blocking ABHD16A activity with KC01 markedly reduced secreted lyso-PS levels in culture and brought elevated lyso-PS levels back down almost to normal in cells derived from PHARC patients. The treatment also greatly reduced the secretion of inflammatory compounds by PHARC-mouse immune cells (macrophages) following exposure to a bacterial toxin.
Finally, the team confirmed the role of ABHD16A by breeding a line of mice whose ABHD16A gene was inactivated. The ABHD16A-knockout animals grew up with lower than usual brain levels of lyso-PSs, and their macrophages showed a correspondingly muted response to immune stimulation.
Cravatt notes he hopes to conduct future research in collaboration with the Howell laboratory to develop a better ABHD16A inhibitor that, unlike THL and KC01, can reach the brain from the bloodstream and thus can be tested in live mice and perhaps in PHARC patients someday. We also think there is a potential for applying the lyso-PS-lowering strategy more broadly against neurological and immunological disorders, said Cravatt.
Other co-authors of the paper, Immunomodulatory lysophosphatidylserines are regulated by ABHD16A and ABHD12 interplay, were Kaddy Camara of the Howell Laboratory at the University of Connecticut; Dong-Hui Chen and Thomas D. Bird of the University of Washington at Seattle, who supplied cell samples from PHARC patients; and William H. Parsons and Melissa M. Dix of the Cravatt Laboratory at TSRI.
Funding for the research was provided in part by the U.S. National Institutes of Health (DA033760), the American Chemical Society, the Hewitt Foundation for Medical Research, the Department of Veterans Affairs and the U.S. National Science Foundation (CHE-0111522 and CHE-1048717).
About The Scripps Research Institute
The Scripps Research Institute (
Most recent headlines
09/11/2025
Dalet today announced a transformative leap forward for media operations: Agentic Artificial Intelligence (AI) that unifies the Dalet ecosystem under one natura...
20/10/2025
Inside TAMS: How Time-Addressable Media Stores could redefine sports workflows By Paul Markham
Friday, October 17, 2025 - 08:57
Print This Story
A penalty...
20/10/2025
Transformational production: Inside TVN's remote production push for the DFL...
20/10/2025
How NBC Sports Transitioned Stamford Facility to One Format: 1080p HDRMulti-year plan harmonizes workflows, simplifies operationsBy Ken Kerschbaumer, Editorial ...
20/10/2025
NBA on NBC' Studio Production Team Is Ready for Tip-Off With Coast-to-Coast...
20/10/2025
Under pressure: TVN CEO Markus Osthaus considers the German sports broadcasting ...
20/10/2025
(L-R) Maria Dizzia, Carmen Emmi, and Russell Tovey attend the Plainclothes pre...
20/10/2025
In March, we launched Concerts Near You to help listeners find concerts from their favorite artists. Since then, more than 3 million people have used it to disc...
20/10/2025
Em diversas cidades do Brasil, um movimento tem se fortalecido para celebrar o poder, a beleza e a profundidade da criatividade negra. O Dia AMPLIFIKA, agora em...
20/10/2025
In cities across Brazil, a movement is growing that celebrates the power, beauty, and depth of Black creativity. AMPLIFIKA Day, now in its fifth edition, return...
20/10/2025
Airborne Early Warning and Control aircraft rendering...
20/10/2025
DENVER and MUNICH Imagine Communications today announced its plans to acquire Pixel Power Ltd., a wholly owned subsidiary of Rohde & Schwarz. Financial terms of...
20/10/2025
LOS ANGELES G Morgan has joined Globecast, a provider of broadcast, media and entertainment managed services, as executive vice president of sales, Globecast Am...
20/10/2025
PLYMOUTH, Wisc. Heartland Video Systems and Zixi have partnered to enable broadcast-quality live video delivery over any IP network....
20/10/2025
A. R. Rahman on Facing Fear and Finding the Divine In an interview with Berklee President Jim Lucchese, the Oscar-winning composer reflects on how courage and...
20/10/2025
Monday 20 October 2025
To view this content, please enable our use of cookies. ...
20/10/2025
Rohde & Schwarz transfers Pixel Power to Imagine Communications Companies work collaboratively to ensure continuity and ongoing support for existing customers...
20/10/2025
RT 's Prime Time is set to host the final Presidential Election Debate this Tuesday night, October 21, providing an opportunity to hear directly from Irelan...
20/10/2025
NVIDIA and Google Cloud are expanding access to accelerated computing to transform the full spectrum of enterprise workloads, from visual computing to agentic a...
19/10/2025
Back to All News
Sins of Kujo' Comes to Life in New Live-Action Series Set for Spring 2026
Entertainment
19 October 2025
GlobalJapan
Link copied to cl...
18/10/2025
New England Sports Network (NESN) has chosen Harmonic, working with Astound Business Solutions, as its enterprise technology partner to transform primary distri...
18/10/2025
NEW ORLEANS, La. In the run-up to the start of the NBA season, WVUE-TV and Gray Local Media have announced a deal with DirecTV that will greatly expand access t...
18/10/2025
Berklee Celebrates 40 Years of the Fall Together Concert Faculty composers Bob Pilkington and Greg Hopkins are among the featured artists for this year's ...
17/10/2025
NEP Group Receives New Equity Investment From 26North Partners LP, Co-InvestorsCarlyle remains the largest shareholder as the company prepares for the futureBy ...
17/10/2025
Apple Lands Five-Year Deal for F1 Distribution in the U.S.Besides airing on Apple TV, the sport will be amplified on other Apple servicesBy Ken Kerschbaumer, Ed...
17/10/2025
SVG Sit-Down: Marshall Electronics' Bernie Keach on the Future of PTZ Camera...
17/10/2025
L2 Productions' REMI Facility in Austin Can Produce Content From AnywhereMusic festivals, sports events are produced via flypacks and remote control roomsBy...
17/10/2025
By Lucy Spicer
One of the most exciting things about the Sundance Film Festival...
17/10/2025
(L-R) Christopher Meyer, Addison Timlin, Cooper Raiff, Lili Reinhart, Alyah Chan...
17/10/2025
M sica e arte se uniram em uma noite especial na semana passada na ZIV Gallery, ...
17/10/2025
Music and art came together for one special night last week at ZIV Gallery, an i...
17/10/2025
Spotify and FC Barcelona are extending our partnership through 2030, continuing a collaboration that's redefining how fans, players, and artists connect. Th...
17/10/2025
MURRIETA, Calif. The Sports Fishing Championship (SFC) has deployed DigitalGlue's creative.space storage platform to streamline video production by centrali...
17/10/2025
BELLEVUE, Wash. Football continued to cement its reputation as a bulwark of TV advertising in Q3 2025 with new data from iSpot that showed both the NFL and coll...
17/10/2025
The Sports Fishing Championship (SFC), the premier competitive saltwater fishing series, has transformed its production workflow by adopting creative.space, the...
17/10/2025
QuickLink, a leading provider of award-winning multi-camera video productions and remote contribution solutions, announces the release of StudioPro Version 4, ...
17/10/2025
Although the annual Grammy Awards celebration is best known for recognizing achievements in the recording industry, the show often proves a visual spectacle as ...
17/10/2025
OpenDrives, Inc., a leading provider of software-defined data storage and data services, has promoted Alex Dunfey to Chief Technology Officer (CTO) from his for...
17/10/2025
The University of Arizona (UofA) has significantly upgraded its broadcast communication infrastructure with the integration of Riedel Communications' advanc...
17/10/2025
Harmonic (NASDAQ: HLIT) today announced that New England Sports Network (NESN), owned by Fenway Sports Group and Delaware North, has selected Harmonic as its en...
17/10/2025
Austin PBS has recently upgraded its facility-wide communications infrastructure, deploying Clear-Com 's Eclipse HX, FreeSpeak II beltpacks, and V-Series ...
17/10/2025
ZEISS announces an open call for the closed BETA testing phase of CinCraft Virtual Lens Technology, the innovative digital tool that brings authentic lens chara...
17/10/2025
Situated in the town of Kokkola, Centria University of Applied Sciences offers higher education across five core fields: engineering, business, social and healt...
17/10/2025
Public information channel in Georgia, USA, to implement a powerful, simple, and cost-effective playout automation platform.
Pebble, the leading automation, co...
17/10/2025
HBO Max is reporting that it has launched in 15 new markets, including Bangladesh, Cambodia, Macau, Pakistan, Sri Lanka and Ukraine, boosting the streaming serv...
17/10/2025
Netflix said it will make a major push into video podcasts, inking a wide-ranging deal with Spotify through which it will offer 16 podcasts in the U.S. starting...
17/10/2025
Lexington, Ky. As part of a push to highlight its advanced advertising capabilities, Viamedia has launched a new AI-powered ad tech platform and officially rebr...
17/10/2025
NEW YORK QuickLink has announced the release of StudioPro Version 4, which the company is calling the most significant upgrade yet to its flagship video product...
17/10/2025
NEW YORK and CUPERTINO, Calif. Apple and NBCUniversal said they will sell Apple TV and Peacock streaming bundles to U.S. subscribers starting Oct. 20....
TSRI Scientists Discover Possible New Target for Treating Brain Inflammation LA JOLLA, CA January 12, 2015 A team led by scientists at The Scripps Research Institute (TSRI) has identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited neurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that inhibit this enzyme.
